Changes in the urine protein profile following intravesical doxorubicin.
D000368:Aged; D001798:Blood Proteins / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000652:urine; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000652:urine; D004317:Doxorubicin / Q000008:administration & dosage*; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D011507:Proteinuria; D001743:Urinary Bladder; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000652:urine*
D001798:Blood Proteins; D002272:Carcinoembryonic Antigen; D005338:Fibrin Fibrinogen Degradation Products; D004317:Doxorubicin